BRIEF-Lilly announces label update for its diabetes drug Trulicity By: Reuters: Company News February 08, 2017 at 07:03 AM EST * Lilly's Trulicity (dulaglutide) label updated to include use in combination with basal insulin for adults with type 2 diabetes Read More >> Related Stocks: Eli Lilly